Open AccessWeniger Lungenschaden mit Tofacitinib bei COVID-19-Pneumonie
Author(s) -
Peter Dovjak
Publication year - 2021
Publication title -
pneumo news
Language(s) - German
Resource type - Journals
eISSN - 2199-3866
pISSN - 1865-5467
DOI - 10.1007/s15033-021-2760-6
Subject(s) - tofacitinib , medicine , covid-19 , virology , rheumatoid arthritis , disease , outbreak , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom